USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GENOMICS USA, INC.
Address:
3450 S. Broadmont
TUCSON, AZ 85710-
Phone:
N/A
URL:
N/A
EIN:
175300185
DUNS:
141832860
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,214,232.00 3
SBIR Phase II $7,044,446.00 3

Award List:

Population-scale HLA typing for home land defense

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$498,784.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Genomics USA, Inc. (GUSA) is a biotech start-up focused on microarray technology development. GUSA has previously developed a combination of genomics IT and microarray technology to enable the mass production of medium-density DNA microarrays at very low cost.… More

HLA Chip Product for FDA 510K Approval

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$2,798,132.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Current technology for HLA typing does not have rapid field response capability because it too expensive and is too complicated to be implemented in the context of a population-scale emergency. The ultimate goal of this proposal is to develop a simple, accurate,… More

A Low Cost Microarray for Population-Scale AIDS Risk Analysis: The AIDS Chip

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$599,686.00
Agency:
HHS
Principal Investigator:
Michael E. Hogan
Abstract:
DESCRIPTION (provided by applicant): There is rapidly growing HIV literature, which has discovered a set of inherited genetic differences which can predict: a) the fraction of an infected population who will progress slowly, or never progress to AIDS sympt oms (the so-called Elite Controllers), or… More

HLA Chip Product for FDA 510K Approval

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$2,513,348.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We describe here a Phase II Competitive Renewal grant application, which will support a three year program of ASHI (American Society of Histocompatibility and Immunology) and FDA 510K review, for the HLA-Chip which we have developed over the past two years,… More

The Transfusion Chip: A Simple, Low Cost Microarray for DNA Based Blood Typing

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$115,762.00
Agency:
HHS
Principal Investigator:
Michael E. Hogan – 847-359-1032
Abstract:
DESCRIPTION (provided by applicant): Low-cost nucleic acid analysis, to detect HIV and HBV, has revolutionized screening of the blood supply. In spite of that new genetic sophistication, traditional blood group typing [ABO, Rh] is still performed, for themost part, via variations upon 80-year-old… More

The Transfusion Chip: Phase II Technology Validation

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,732,966.00
Agency:
HHS
Principal Investigator:
Michael E. Hogan – 520-904-1715
Abstract:
DESCRIPTION (provided by applicant): Blood-Typing is the progenitor of the entire field of personalized medicine. In the recently awarded 6-month Phase I, we proposed to take the first step in the development of an extremely-low-cost microarray test, TheTransfusion-Chip (T-Chip) which convert the… More